Funds and ETFs Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:35:07 2024-05-21 pm EDT 5-day change 1st Jan Change
103 USD -0.18% Intraday chart for Abbott Laboratories -1.05% -6.50%

ETFs positioned on Abbott Laboratories

Name Weight AuM 1st Jan change Investor Rating
7.18% 17 M€ +7.97% -
5.19% 2 M€ -.--%
3.00% 2 M€ -.--% -
2.34% 9 M€ -.--% -
2.04% 9 M€ 0.00%
2.02% 1 M€ +16.32%
1.88% 2 M€ +21.73% -
1.80% 5 M€ -72.95% -
1.76% 1 M€ +2.21% -
1.30% 37 M€ -.--%
1.20% 2 M€ +10.27%
1.12% 8 M€ +5.66%
1.00% 204 M€ +10.54%
0.94% 330 M€ -.--%
0.83% 85 M€ +14.34% -
0.77% 265 M€ +7.19% -
0.76% 273 M€ -.--%
0.76% 655 M€ -.--% -
0.76% 1,174 M€ +23.54%
0.76% 104 M€ +10.73%
0.69% 26 M€ +22.35% -
0.67% 8 M€ +5.48% -
0.66% 1,848 M€ +18.39% -
0.66% 559 M€ +14.30%
0.65% 1 M€ +0.04%
0.60% 744 M€ +9.42%
0.60% 8 M€ +7.41% -
0.60% 6 M€ +17.98% -
0.60% 121 M€ +8.59% -
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
103.2 USD
Average target price
126.1 USD
Spread / Average Target
+22.22%
Consensus
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. Funds and ETFs Abbott Laboratories
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW